Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Membrell
Carthage, Missouri, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Clinical studies show Membrell’s NEM (Natural Eggshell Membrane) leads to significant improvements in joint pain and flexibility in as little as 7–10 days, with sustained effects over 30 days. Eggshell calcium (ESC) in their bone health products is also clinically shown to increase bone mineral density, particularly in post-menopausal women[1][2][3][5].
- Therapeutic areas
- EndocrinologyRheumatology
- Modalities
- ProteinGlycosaminoglycanCollagenSmall molecule
- Industry
- Food & Nutrition
02
Partnerships
ESM Technologies (ingredient/process development)Allera (distribution partnership for Immune Extra products)
Beyond the preview
Go deeper on Membrell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Membrell.